Results 201 to 210 of about 223,515 (301)

Genotype and Age at Onset Drive Vermis Atrophy in CACNA1A- and GAA-FGF14-related Ataxias. [PDF]

open access: yesCerebellum
Indelicato E   +10 more
europepmc   +1 more source

ART Innsbruck 9. Internationale Kunstmesse, 25.-28.2.2005 [PDF]

open access: yes, 2005
Verein zur Förderung der Kunst und der Art Innsbruck   +2 more
core  

Oxaliplatin‐induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life

open access: yesInternational Journal of Cancer, Volume 159, Issue 1, Page 198-209, 1 July 2026.
What's New? Oxaliplatin serves a key role in the treatment of rectal cancer, though it is a significant cause of chemotherapy‐induced peripheral neuropathy. As total neoadjuvant therapy, in which all therapy is given before surgery, has become more common, understanding neuropathy has grown increasingly important. This study examined neuropathy and its
Georg W. Wurschi   +29 more
wiley   +1 more source

Issue Information

open access: yesEuropean Journal of Sport Science, Volume 26, Issue 8, August 2026.
No abstract is available for this article.
wiley   +4 more sources

Prevalence, Disease Onset and Clinical Outcome in Arginase 1 Deficiency: Cross‐Border Surveillance in Germany, Austria, and Switzerland

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 4, July 2026.
ABSTRACT Arginase 1 deficiency (ARG1‐D) is an ultra‐rare urea cycle disorder characterized by progressive spastic paraplegia, developmental delay, epilepsy, and episodic hyperammonemia. Evidence on prevalence and clinical presentation is scarce. Therefore, epidemiology and the phenotypical spectrum were assessed in Germany, Austria, and Switzerland ...
Svenja Scharre   +19 more
wiley   +1 more source

PPARα deficiency causes skin dysbiosis and triggers innate immunity in keratinocytes. [PDF]

open access: yesCell Death Dis
Blunder S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy